08/21/2025
Big news at Molecular You!
We’ve just closed a US $5 million Series A round led by Voloridge Health, with support from Dynamic Leap and other strategic investors!
This capital accelerates our mission to move healthcare from reactive to predictive and preventive by scaling our multi‑omic blood test that analyzes 250+ biomarkers across 25+ health areas from a single tube of blood.
With the funding we will:
▪ Expand nationwide across both consumer and clinical channels in North America.
▪ Launch our next‑gen assay measuring 800+ biomarkers for even deeper insights.
▪ Build on key partnerships like our LDT collaboration with HealthQuest Esoterics to unlock insurance reimbursement and make precision prevention accessible to millions.
“Our platform gives individuals and their providers earlier, clearer signals so the right action happens sooner,” says CEO Jim Kean.
👉 Read the full announcement to see how we’re setting a new standard for precision health and what’s next for Molecular You: https://lnkd.in/e6nxtPTg
